Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Henry Klassen, MD, PhD
jCyte, Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Associated Retina Consultants
Phoenix, Arizona, United States
Benjamin Bakall, MD, PhDRecruiting - California Retina Consultants
Bakersfield, California, United States
Dante Pieramici, MD, FASRSRecruiting - Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
David Liao, MD, PhDRecruiting - Gavin Herbert Eye Institute, Uc Irvine
Irvine, California, United States
Mitul Mehta, MD, MSRecruiting - Retina Consultants Medical Group
Sacramento, California, United States
David Telander, MD, PhDRecruiting - Bay Area Retina Associates
Walnut Creek, California, United States
Roger Goldberg, MDRecruiting - Vitreo Retinal Associates
Gainesville, Florida, United States
Christine Kay, MDRecruiting - Georgia Retina
Marietta, Georgia, United States
David Chin Yee, MDRecruiting - Illinois Retina Associates
Oak Park, Illinois, United States
Mathew W MacCumber, MD, PhDRecruiting - Njretina
Teaneck, New Jersey, United States
Luis Gonzalez, MDRecruiting - Long Island Vitreoretinal Consultants
Westbury, New York, United States
Philip Ferrone, MDRecruiting - Retina Consultants of Texas: Bellaire Retina Center
Bellaire, Texas, United States
Kenneth Fan, MDRecruiting - Retina Consultants of Texas: San Antonio
San Antonio, Texas, United States
Jeremiah Brown, MDRecruiting - the Retina Group of Washington
Fairfax, Virginia, United States
Joshua Levinson, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jun 2025
- Primary completion
- 30 Sept 2026
- Completion
- 30 Sept 2026
- Last update posted
- 13 Apr 2026
- Registered enrollment
- 60
- Registry id
- NCT06912633
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.